KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Liabilities and Shareholders Equity (2016 - 2025)

Cvs Health's Liabilities and Shareholders Equity history spans 17 years, with the latest figure at $253.5 billion for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity changed 0.13% year-over-year to $253.5 billion, compared with a TTM value of $1022.8 billion through Dec 2025, up 1.48%, and an annual FY2025 reading of $253.5 billion, changed 0.13% over the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $253.5 billion at Cvs Health, down from $255.3 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $258.3 billion in Q2 2025, with the low at $228.3 billion in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $243.6 billion, with a median of $249.7 billion recorded in 2023.
  • Year-over-year, Liabilities and Shareholders Equity decreased 2.03% in 2022 and then increased 9.4% in 2023.
  • Tracing CVS's Liabilities and Shareholders Equity over 5 years: stood at $233.0 billion in 2021, then fell by 2.03% to $228.3 billion in 2022, then grew by 9.4% to $249.7 billion in 2023, then rose by 1.4% to $253.2 billion in 2024, then rose by 0.13% to $253.5 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Liabilities and Shareholders Equity are $253.5 billion (Q4 2025), $255.3 billion (Q3 2025), and $258.3 billion (Q2 2025).